Technology

Technology

How HLS’s Platform Works

Our dual-acting anti-infectives kill bacteria by preventing their interaction with nutrient accumulation. This results through effects of bacterial two-component systems, blocking gene function. The bacteria die in minutes. The chance of developing resistance to our anti-infectives is approximately 1 chance in 10 followed by 104 zeros, thus extremely unlikely.

Screen Shot 2015-09-15 at 12.01.00 AM

Below is Patrick Schlievert, PhD–Founder and Board Member demonstrating one of the dual-acting anti-infectives as a clear gel that can be used on skin and mucosal surfaces to kill bacterial and prevent inflammation.

Screen Shot 2015-09-15 at 12.25.12 AM  

 

MRSA (Left) and MRSA Exposed to GML Gel (Right)

MRSA (Left) and MRSA Exposed to GML Gel (Right)

 

Candida Auris (Left) and Candida Exposed to GML Gel (right)

Candida Auris (Left) and Candida Exposed to GML Gel (right)

 

GML Gel Selects for Lactobacilli

GML Gel Selects for Lactobacilli